Evernorth Health Services Announces $3.5 Billion Investment in Shields Health Solutions
On September 2, 2025, Evernorth Health Services, a subsidiary of The Cigna Group, announced a $3.5 billion investment in Shields Health Solutions, a Stoughton, Massachusetts-based leader in specialty pharmacy management. The investment supports Sycamore Partners’ $10 billion acquisition of Walgreens Boots Alliance (WBA) in August 2025, which restructured WBA into five independent entities, including Shields as a private standalone company. Shields partners with more than 80 health systems, represents more than 1,000 hospitals and clinics across nearly all 50 states and serves more than seven million patients across more than 30 integrated disease states. Its Shields Performance Platform... Read More »
Cigna Sells Evernorth Care Group to HonorHealth
HonorHealth announced on September 3 that it has entered into an agreement with The Cigna Group to bring Evernorth Care Group’s clinic locations into the HonorHealth family. Evernorth Care Group operates 18 clinics in the Phoenix, Arizona MSA and provides integrated primary care services to nearly 80,000 patients. HonorHealth is a nonprofit, local healthcare system serving an area of 1.6 million people in the Phoenix MSA. The network encompasses six acute-care hospitals, an extensive medical group, outpatient surgery centers, a cancer care network, clinical research, medical education, a foundation and community services. It has approximately 13,700 team members, 3,700 affiliated... Read More »
Echo Real Estate Capital Sells Medical Outpatient Building in Massachusetts
Echo Real Estate Capital announced the sale of an on-campus medical outpatient building (MOB) for $9.57 million dollars. The acquirer was not disclosed. The MOB is approximately 59,000 square feet and is located in Haverhill, Massachusetts on the campus of the 122-bed Lawrence General Holy Family Hospital. The building was roughly 90% occupied at the time of sale by 20 tenants that include Revere Medical, Northeast Rehab, Mobility Bone and Joint Institute and PhyNet Dermatology. “This was an incredible outcome for a heavy value-add transaction. We acquired the building in 2021 which was a much different investment climate,” said Echo principal Jon Boyajian. “Half-way through... Read More »
beBright Acquires Brink & White Pediatric Dental Associates
beBright, based in Minnetonka, Minnesota, announced the acquisition of Brink & White Pediatric Dental Associates. Brink & White Pediatric Dental Associates is a pediatrics dental practice with three locations in the Memphis, Tennessee MSA (Bartlett, Lakeland and Munford). According to its website, there are four physicians on staff. beBright is a doctor-owned and -led pediatric dentistry and orthodontic services organization. The company was created by New York-based private equity firm InTandem Capital Partners in June 2023. This transaction marks beBright’s second acquisition of 2025. The financial terms were not disclosed. According to data captured... Read More »
MB2 Dental Acquires Tidewater Laser Perio and Implants
MB2 Dental Solutions, a portfolio company of Warburg Pincus and Charlesbank Capital Partners, announced that it entered into its 10th acquisition of 2025 with the purchase of Tidewater Laser Perio and Implants. Based in Virginia Beach, Virginia, Tidewater Laser Perio and Implants is run by Dr. Kenneth J. Cavallari, DDS, who is supported by a team of 10, including four surgical technicians. MB2 Dental Solutions partners with dentists and specialists. Founded in 2007, MB2 offers general dentistry services, orthodontics, cosmetic dentistry and oral surgery. Since 2021, it has been part of Charlesbank Capital Partners’ network. In November 2024, Warburg Pincus invested in the... Read More »
CapVest To Buy Majority Stake In STADA
CapVest Partners has signed an agreement with Bain Capital and Cinven to acquire a majority stake in STADA Arzneimittel AG. STADA Arzneimittel manufactures and distributes specialty pharmaceuticals and non-prescription consumer health products. Located in Bad Vilbel, Germany, STADA has evolved from a traditional generics business into a diversified global healthcare platform since its acquisition by Bain Capital and Cinven in 2017. CapVest Partners is an established European mid-market private equity firm focused on acquiring market leading companies supplying essential products and services. CapVest was formed in 1999 and is based in London. The lead financial advisors to CapVest were... Read More »
French Genomic Analysis Firm SeqOne Acquires U.K.-Based Congenica
SeqOne announced on September 2 that it has entered into a definitive agreement to acquire Congenica, a British company spun out of the Wellcome Sanger Institute. Founded in 2012, Congenica services more than 25 private and public labs, including multiple NHS Genomics Laboratory Hubs and national programs such as Genomics England and the Hong Kong Genomic Program. SeqOne’s AI-powered genomic analysis platform, providing clinical decision-support tools that enable molecular laboratories to deliver fast, accurate and scalable analysis of genetic data for applications in oncology, rare and inherited diseases and infectious diseases. The company now serves a global customer base of... Read More »
Epiphany Dermatology Acquires Dermatology Associates, LLP
Epiphany Dermatology announced that it expanded its presence in Texas with the acquisition of Dermatology Associates, LLP. Dermatology Associates is based in one location in Texarkana, Texas. According to its website, there is one physician on staff (Dr. Jeff Young) who is supported by one nurse practitioner and one medical aesthetician/technician. Through its partnerships with dermatologists in more than 100 locations in Arizona, Colorado, Georgia, Iowa, Kansas, Maryland, Minnesota, Missouri, Montana, Nevada, New Mexico, Oklahoma, South Carolina, Texas, Utah, Washington and Wyoming, Epiphany provides general dermatology, skin cancer care, Mohs surgery, cosmetic services and... Read More »
Inside the 2025 Telehealth M&A Market
After several years of heightened dealmaking, telehealth M&A has settled into a steadier rhythm in 2025. Investors and acquirers are still active, but the focus has shifted from the rapid expansion of the pandemic years to more targeted, strategic transactions. As of August 29, 2025, 32 telehealth deals have been announced, representing 15% of the 210 eHealth transactions year to date. That marks only a slight increase in volume over the same period in 2024 when 29 deals (18% of 162 eHealth transactions) were recorded. Telehealth M&A activity in 2025 is slower than the peak years of 2021 to 2023. Deal volume was modest before the surge, with 20 deals in 2017, 12 in 2018, and 24 in... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
